Predictive Oncology Inc. POAI NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

29/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

共有 50 笔近期内部人交易记录记录，涉及 Predictive Oncology Inc. (POAI), 包括 44 笔买入 和 3 笔卖出. 内部人买入总额为 $13.41K 内部人卖出总额为 $31.9K.

近期活跃的重要内部人包括 Nuzum Charles Lee Sr, Hawryluk Matthew, Handley Daniel E. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — POAI

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2024-04-05	Nuzum Charles Lee Sr	Director	限制性股票授予 (RSU)	3,268	-	-	31,921
2024-04-05	Hawryluk Matthew	Director	限制性股票授予 (RSU)	2,368	-	-	9,488
2024-04-05	Handley Daniel E	Director	限制性股票授予 (RSU)	2,353	-	-	18,661
2024-04-05	Chung-welch Nancy	Director	限制性股票授予 (RSU)	2,353	-	-	21,237
2024-04-05	St. Clair Gregory Sr	Director	限制性股票授予 (RSU)	3,268	-	-	22,534
2024-04-05	Rao Veena	Director	限制性股票授予 (RSU)	3,268	-	-	9,117
2023-10-02	Nuzum Charles Lee Sr	Director	限制性股票授予 (RSU)	2,605	-	-	26,638
2023-10-02	Hawryluk Matthew	Director	限制性股票授予 (RSU)	1,875	-	-	7,135
2023-10-02	Handley Daniel E	Director	限制性股票授予 (RSU)	1,875	-	-	14,665
2023-10-02	Chung-welch Nancy	Director	限制性股票授予 (RSU)	1,875	-	-	16,960
2023-10-02	St. Clair Gregory Sr	Director	限制性股票授予 (RSU)	1,875	-	-	17,934
2023-10-02	Rao Veena	Director	限制性股票授予 (RSU)	1,875	-	-	5,849
2023-09-25	Nuzum Charles Lee Sr	Director	知情卖出	10,000	$3.04	$30.39K	24,033
2023-09-25	Myers Robert L	Chief Financial Officer	RSU 预扣税	510	$2.96	$1.51K	4,720
2023-07-03	Nuzum Charles Lee Sr	Director	限制性股票授予 (RSU)	3,773	-	-	34,033
2023-07-03	Hawryluk Matthew	Director	限制性股票授予 (RSU)	2,675	-	-	5,260
2023-07-03	Handley Daniel E	Director	限制性股票授予 (RSU)	2,675	-	-	12,790
2023-07-03	Chung-welch Nancy	Director	限制性股票授予 (RSU)	2,675	-	-	15,085
2023-07-03	St. Clair Gregory Sr	Director	限制性股票授予 (RSU)	3,773	-	-	16,059
2023-07-03	Rao Veena	Director	限制性股票授予 (RSU)	2,675	-	-	3,974
2023-05-12	Rao Veena	Director	限制性股票授予 (RSU)	1,299	-	-	1,299
2023-05-02	Rao Veena	Officer	未知	-	-	-	-
2023-04-03	Nuzum Charles Lee Sr	Officer	限制性股票授予 (RSU)	25,499	-	-	605,203
2023-04-03	Hawryluk Matthew	Officer	限制性股票授予 (RSU)	18,360	-	-	51,692
2023-04-03	Handley Daniel E	Officer	限制性股票授予 (RSU)	18,360	-	-	202,295
2023-04-03	Chung-welch Nancy	Officer	限制性股票授予 (RSU)	18,360	-	-	248,199
2023-04-03	St. Clair Gregory Sr	Officer	限制性股票授予 (RSU)	25,499	-	-	245,710
2023-04-03	Smith David Stewart	Officer	限制性股票授予 (RSU)	18,360	-	-	109,026
2023-01-31	Bush Pamela	Officer	处置	-	-	-	47,373
2023-01-25	Nuzum Charles Lee Sr	Director	限制性股票授予 (RSU)	53,539	-	-	579,704
2023-01-03	Nuzum Charles Lee Sr	Director	限制性股票授予 (RSU)	172,150	-	-	526,165
2023-01-03	Hawryluk Matthew	Director	限制性股票授予 (RSU)	19,570	-	-	33,332
2023-01-03	Handley Daniel E	Director	限制性股票授予 (RSU)	63,422	-	-	183,935
2023-01-03	Chung-welch Nancy	Director	限制性股票授予 (RSU)	97,848	-	-	229,839
2023-01-03	St. Clair Gregory Sr	Director	限制性股票授予 (RSU)	99,664	-	-	220,211
2023-01-03	Vennare Raymond F	Chief Executive Officer	限制性股票授予 (RSU)	58,708	-	-	142,438
2023-01-03	Smith David Stewart	Director	限制性股票授予 (RSU)	71,755	-	-	90,666
2022-12-15	Handley Daniel E	Director	知情买入	6,000	$0.41	$2.46K	120,513
2022-12-02	Myers Robert L	Chief Financial Officer	知情买入	8,795	$0.57	$5K	71,265
2022-12-02	Vennare Raymond F	Director	知情买入	4,600	$0.52	$2.38K	83,330
2022-12-01	Hawryluk Matthew	Director	限制性股票授予 (RSU)	13,762	-	-	13,762
2022-11-29	Handley Daniel E	Director	知情买入	10,000	$0.36	$3.58K	114,513
2022-11-29	Hawryluk Matthew	Officer	未知	-	-	-	-
2022-11-01	Engle J Melville	Director	限制性股票授予 (RSU)	213,300	-	-	416,693
2022-10-25	Smith David Stewart	Director	限制性股票授予 (RSU)	18,911	-	-	18,911
2022-10-19	Smith David Stewart	Officer	未知	-	-	-	-
2022-10-03	Nuzum Charles Lee Sr	Director	限制性股票授予 (RSU)	23,147	-	-	354,015
2022-10-03	Handley Daniel E	Director	限制性股票授予 (RSU)	23,147	-	-	104,513
2022-10-03	Chung-welch Nancy	Director	限制性股票授予 (RSU)	23,147	-	-	131,991
2022-10-03	St. Clair Gregory Sr	Director	限制性股票授予 (RSU)	23,147	-	-	120,547